James Samuel Shannon is of Xilio Therapeutics, Inc.. Currently has a direct ownership of 70,000 shares of XLO, which is worth approximately $47,600. The most recent transaction as insider was on Jun 17, 2025, when has been sold 25,000 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $17,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 70K
n/a 3M change
n/a 12M change
Total Value Held $47,600

James Samuel Shannon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 17 2025
BUY
Open market or private purchase
$17,250 $0.69 p/Share
25,000 Added 26.32%
70,000 Common Stock
Jun 16 2025
BUY
Open market or private purchase
$31,049 $0.69 p/Share
45,000 Added 50.0%
45,000 Common Stock

Also insider at

HZNP
Horizon Therapeutics Public Ltd Co Healthcare
MNKD
MANNKIND CORP Healthcare
JSS

James Samuel Shannon

Dublin, L2

Track Institutional and Insider Activities on XLO

Follow Xilio Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XLO shares.

Notify only if

Insider Trading

Get notified when an Xilio Therapeutics, Inc. insider buys or sells XLO shares.

Notify only if

News

Receive news related to Xilio Therapeutics, Inc.

Track Activities on XLO